JPY 398.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.08 Billion | -1.16 Billion | 3.14 Billion | -137 Million | -1.54 Billion | 2.81 Billion |
Net Income | 415 Million | 226 Million | 1.11 Billion | 1.8 Billion | 925 Million | 878 Million |
Depreciation & Amortization | 689 Million | 657 Million | 596 Million | 557 Million | 628 Million | 502 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -2.57 Billion | -1.65 Billion | 2.23 Billion | -2.26 Billion | -2.75 Billion | 1.51 Billion |
Other non-cash items | 4.68 Billion | -392 Million | -792 Million | -233 Million | -351 Million | -81 Million |
Investing Cash Flow | -1.45 Billion | -1.1 Billion | -1.08 Billion | -878 Million | -913 Million | -618 Million |
Investments in PPE | -1.42 Billion | -1.05 Billion | -828 Million | -869 Million | -907 Million | -612 Million |
Acquisitions | - | - | -294 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -35 Million | -50 Million | 39 Million | -9 Million | -6 Million | -6 Million |
Financing Cash Flow | 2.42 Billion | 1.32 Billion | -287 Million | 912 Million | 2.08 Billion | -1.47 Billion |
Debt repayment | -2.58 Billion | -750 Million | -878 Million | -734 Million | -534 Million | -411 Million |
Dividends payments | -162 Million | -162 Million | -214 Million | -160 Million | -178 Million | -159 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 4 Million | 2.23 Billion | 805 Million | 1.8 Billion | 2.8 Billion | -902 Million |
Accounts receivables | -4.52 Billion | -391 Million | -534 Million | -252 Million | -2.06 Billion | 456 Million |
Accounts payables | 1.85 Billion | -1.05 Billion | 1.31 Billion | -1.82 Billion | 545 Million | -316 Million |
Inventory | -255 Million | -13 Million | 597 Million | -108 Million | -136 Million | 201 Million |
Other working capital | 353 Million | -199 Million | 859 Million | -81 Million | -1.09 Billion | 1.17 Billion |
Cash at beginning of period | 2.32 Billion | 3.25 Billion | 1.47 Billion | 1.55 Billion | 1.95 Billion | 1.22 Billion |
Cash at end of period | 2.2 Billion | 2.32 Billion | 3.25 Billion | 1.47 Billion | 1.57 Billion | 1.95 Billion |
Capital Expenditure | -1.42 Billion | -1.05 Billion | -828 Million | -869 Million | -907 Million | -612 Million |
Effect of forex changes on cash | - | 1 Million | -1 Million | 29 Million | -1 Million | -1 Million |
Net cash flow / Change in cash | -119 Million | -934 Million | 1.77 Billion | -74 Million | -374 Million | 724 Million |
Free Cash Flow | -2.5 Billion | -2.21 Billion | 2.32 Billion | -1 Billion | -2.45 Billion | 2.2 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -113 Million | 344 Million | 415 Million | 161 Million | -70 Million | -20 Million |
Depreciation & Amortization | - | - | 689 Million | 174 Million | 164 Million | 157 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -2.57 Billion | - | - | - |
Other non-cash items | 113 Million | -344 Million | 4.68 Billion | -161 Million | 70 Million | 20 Million |
Investing Cash Flow | - | - | -1.45 Billion | - | - | - |
Investments in PPE | - | - | -1.42 Billion | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -35 Million | - | - | - |
Financing Cash Flow | - | - | 2.42 Billion | - | - | - |
Debt repayment | - | - | -2.58 Billion | - | - | - |
Dividends payments | - | - | -162 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 4 Million | - | - | - |
Accounts receivables | - | - | -4.52 Billion | - | - | - |
Accounts payables | - | - | 1.85 Billion | - | - | - |
Inventory | - | - | -255 Million | - | - | - |
Other working capital | - | - | 353 Million | - | - | - |
Cash at beginning of period | - | - | 2.32 Billion | 1.88 Billion | 3.07 Billion | 2.32 Billion |
Cash at end of period | - | - | 2.2 Billion | 1.64 Billion | 1.88 Billion | 3.07 Billion |
Capital Expenditure | - | - | -1.42 Billion | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -119 Million | -242 Million | -1.19 Billion | 754 Million |
Free Cash Flow | - | - | -2.5 Billion | 348 Million | 328 Million | 314 Million |
1304
EBSH
TWL
3699
9520
CHDCHEM